LAURIE J OLSON
CIK 1553231 · Executive Vice President · last filed 2024-05-14
LAURIE J OLSON is an Executive Vice President who has filed 71 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing shows the insider sold $25.5K of QTRX on May 14, 2024. Across all open-market trades the lifetime net is −$4.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.09M
3
71
-$4.82M
Holdings By Company
Recent Filings
71 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-14 | QTRX | Sell (S) | −1,500 | -$25.5K | EDGAR |
| 2024-04-02 | QTRX | Mixed | — | -$10.6K | EDGAR |
| 2024-03-18 | Karuna Therapeutics, Inc. (KRTX) Delisted | Disp (D) | −990 | -$326.7K | EDGAR |
| 2024-02-15 | QTRX | Sell (S) | −1,500 | -$36.5K | EDGAR |
| 2024-01-04 | QTRX | Mixed | +2,947 | -$14.1K | EDGAR |
| 2023-11-14 | QTRX | Sell (S) | −1,500 | -$32.8K | EDGAR |
| 2023-07-05 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | — | -$130.8K | EDGAR |
| 2023-06-22 | Karuna Therapeutics, Inc. (KRTX) Delisted | Grant (A) | +990 | $0 | EDGAR |
| 2023-04-05 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | — | -$96.2K | EDGAR |
| 2023-01-05 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | — | -$112.6K | EDGAR |